期刊文献+

大鼠非酒精性脂肪性肝纤维化形成过程中骨桥蛋白的表达及其意义 被引量:4

The expression and significance of osteopontin in the development of nonalcoholic fatty liver fibrosis in rats
原文传递
导出
摘要 目的通过观察非酒精性脂肪性肝纤维化形成过程中肝组织内骨桥蛋白(OPN)的变化规律,探讨OPN在非酒精性脂肪性肝纤维化形成过程中的作用。方法选用纯系Wistar雄性大鼠56只,体质量180-200g,随机分为正常对照组和高脂饮食4、8、12、16、20、24周组(其中每组各8只)。肝组织常规进行HE及Masson三色胶原染色,免疫组织化学染色检测肝组织a-平滑肌肌动蛋白的表达,RT-PCR、Western blot观察肝组织中OPN动态变化。结果与正常对照组相比,高脂饲料组大鼠肝脏内OPN含量明显升高,随着脂肪肝程度的加重,OPN表达逐渐增强,mRNA及蛋白质表达比较,F值分别为7.30和7.15,P值均〈0.01;与a-平滑肌肌动蛋白表达及肝组织胶原纤维面积百分比呈显著正相关(r值分别为0.94和0.82,P值均〈0.01)。结论在非酒精性脂肪性肝纤维化形成过程中,OPN在肝组织中表达显著上调,可能在非酒精性脂肪性肝纤维化的形成过程中发挥重要作用。 Objective To investigate the changes of osteopontin (OPN) in the liver tissues during nonalcoholic fatty liver fibrosis in rats and to explore the effect of OPN in the development of nonalcoholic fatty liver fibrosis. Methods Fifty-six male Wtstar rats were randomly divided into a control group (8 rats) and a high-fat diet group. The high-fat diet group was divided into 6 subgroups (8 rats in each subgroup) with high-fat feedings for 4, 8, 12, 16, 20 or 24 weeks. Conventional histochemical, HE, Masson-trichrome and immunohistochemical staining for a -smooth muscle actin ( a-SMA) were performed with the liver histological preparations. The expression of OPN was detected with reverse transcription and polymerase chain reactions and Western blot. Results Levels of OPN in liver tissues in rat nonalcoholic fatty liver fibrosis induced by high-fat diet were significantly increased over those in the control group (F = 7.15, P 〈 0.01). OPN expressions were closely correlated with a -SMA and nonalcoholic fatty liver fibrosis, and correlation coefficients of the two groups were 0.94 and 0.82, and both P values were less than 0.01. Conclusion Expression of OPN increases dramatically in the livers during the development of nonalcoholic fatty liver fibrosis, and OPN may play an important role in this event.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2008年第11期831-834,共4页 Chinese Journal of Hepatology
关键词 脂肪肝 非酒精性 肝纤维化 骨桥蛋白 Fatty liver, nonalcoholic Liver fibrosis Osteopontin
  • 相关文献

参考文献10

  • 1王晓敏,陈东风.罗格列酮对非酒精性脂肪性肝炎大鼠肝组织Kruppule样因子6信号通路的影响[J].中华肝脏病杂志,2007,15(9):649-653. 被引量:2
  • 2Zahradka P. Novel role for osteopontin in cardiac fibrosis. Circ Res, 2008, 102: 270-272.
  • 3Philip S, Bulbule A, Kundu GC. Matrix metaUoproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion. Glycoconj J, 2004, 21: 429-441.
  • 4徐正婕,范建高,王国良,丁晓东,田丽艳,郑晓英.高脂饮食致大鼠非酒精性脂肪性肝炎肝纤维化模型[J].世界华人消化杂志,2002,10(4):392-396. 被引量:83
  • 5Mazzali M, Kipari T, Ophascharoensuk V, et al. Osteopontin-a molecule for all seasons. QJM, 2002, 95: 3-13.
  • 6Johnson GA, Burghardt RC, Bazer FW, et al. Osteopontin: roles in implantation and placentation. Biol Reprod, 2003, 69: 1458-1471.
  • 7Shui HA, Ka SM, Yang SM, et al. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis. Transl Res, 2007, 150: 216- 222.
  • 8Hardie WD, Korfhagen TR, Sartor MA, et al. Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis. Am J Respir Cell Mol Biol, 2007, 37: 309-321.
  • 9Lorena D, Darby IA, Gadeau AP, et al. Osteopontin expression in normal and fibrotic liver, altered liver healing in osteopontin-deficient mice. J Hepatol, 2006, 44: 383-390.
  • 10Lee SH, Seo GS, Park YN, et al. Effects and regulation of osteopontin in rat hepatic stellate ceils. Biochem Pharmacol, 2004, 68: 2367- 2378.

二级参考文献10

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1518
  • 2王晓敏,陈东风.核转录因子KLF6在非酒精性脂肪性肝纤维化形成中的作用[J].消化外科,2006,5(5):355-360. 被引量:5
  • 3Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology, 2003, 38: 1008- 1017.
  • 4Hammarstedt A, Andersson CX, Rotter Sopasakis V, et al. The effect of PPARgamma ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot Essent Fatty Acids, 2005, 73:65- 75.
  • 5Singh N, Webb R, Adams R, et al. The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calcium. Biochem Biophys Res Commun, 2005, 333: 455-462.
  • 6Sanchez-Hidalgo M, Marti AR, Villegas I, et al. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochem Pharmacol, 2005, 69: 1733-1744.
  • 7Abdelrahman M, Sivarajah A, Thiemermann C. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res, 2005, 65:772-781.
  • 8Gehrau RC, D'Astolfo DS, Prieto C, et al. Genomic organization and functional analysis of the gene encoding the Kriippel-like transcription factor KLF6. Biochim Biophys Acta, 2005, 1730: 137- 146.
  • 9Wang L, Potter J J, Rennie-Tankersley L, et al. Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice. Biochim Biophys Acta, 2007, 1772: 66-71.
  • 10杨燕,吴铁,何康.有氧运动及联用人参茎叶皂苷对高脂血症小鼠脂质代谢的干预作用[J].中国药理学通报,1999,15(1):65-67. 被引量:19

共引文献83

同被引文献32

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部